Showing results (131-140 of 143) with videos related to

Sort By:
Pageof 15
Cancer Cell|October 22, 2011
An antioxidant response phenotype shared between hereditary and sporadic type 2 papillary renal cell carcinomaAikseng Ooi, Jing-Chii Wong, David Petillo, et al.
BMC Medical Genomics|December 18, 2010
Birt-Hogg-Dubé renal tumors are genetically distinct from other renal neoplasias and are associated with up-regulation of mitochondrial gene expressionJeff A Klomp, David Petillo, Natalie M Niemi, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 3, 2025
Artificial Intelligence (AI)-Driven Screening of Equivocal Prostate Immunohistochemistry (IHC) Cases: Development and Validation of a Screening and Cancer Detection FrameworkRamin Nateghi, Ruoji Zhou, Madeline Saft, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 22, 2018
Anaplastic Lymphoma Kinase Mutation (ALK F1174C) in Small Cell Carcinoma of the Prostate and Molecular Response to AlectinibBenedito A Carneiro, Sahithi Pamarthy, Ami N Shah, et al.
Kidney International|June 18, 2015
Disruption of tubular Flcn expression as a mouse model for renal tumor inductionJindong Chen, Dachuan Huang, Isabelle Rubera, et al.
BMC Cancer|May 14, 2010
Genomic expression and single-nucleotide polymorphism profiling discriminates chromophobe renal cell carcinoma and oncocytomaMin-Han Tan, Chin Fong Wong, Hwei Ling Tan, et al.
Breast Cancer Research and Treatment|July 5, 2024
A randomized phase III double-blind placebo-controlled trial of first-line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu-positive metastatic breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1105)Jessica Mezzanotte-Sharpe, Anne ONeill, Ingrid A Mayer, et al.
Research Square|May 15, 2024
A randomized phase III double-blind placebo-controlled trial of first line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu-positive metastatic breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1105)Jessica Mezzanotte-Sharpe, Anne ONeill, Ingrid A Mayer, et al.
The Journal of Urology|March 17, 2025
Negative Predictive Value of a Prostate MRI in Black Men: Implications for Biopsy Decision-MakingSarah Sandlow, Samuel Carbunaru, Zequn Sun, et al.
Cancer Research|July 5, 2005
A molecular classification of papillary renal cell carcinomaXiming J Yang, Min-Han Tan, Hyung L Kim, et al.
Pageof 15